Skip to content
★ Sign in to follow
BF

Bengt Fellström

Hansa Biopharma AB
Total declarations
4
Company
1
▲ Purchases (2 ops.)
€399k
▼ Sales (2 ops.)
€321k

Latest filing published 13 Jul 2018 for Hansa Biopharma AB, €86k.

Filing timeline

BuySale
Bengt Fellström

Insider track record

Disclosed buys
2
Disclosed sells
2
Signal history

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Bengt Fellström: trading record in brief

Bengt Fellström is a declared insider of Hansa Biopharma AB, with filings sourced from Finansinspektionen. In total, 4 filings cover trades dated from 27 June 2018 to 11 July 2018.

Market trades split into 2 purchases (€399k) and 2 sales (€321k). Purchases outweigh sales by €78k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

The newest entry dates from 13 July 2018: an open-market sale of €86k, in Hansa Biopharma AB. The most recent open-market purchase was published on 13 July 2018, 3,041 days ago. Filings reach the Finansinspektionen feed a median of 4 days after the trade. The regulation allows three business days to notify a trade (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Companies and markets linked to Bengt Fellström

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ▼
    KonsultExecutivesHansa Biopharma AB
    884,000 SEK21FI-SE
    4,000 shares@ SEK 221.0012.0% of flowISIN SE0002148817FI:csv-b9836c29cdc4ddac5b6b
  • ▲
    KonsultExecutivesHansa Biopharma AB
    1M SEK4FI-SE
    6,000 shares@ SEK 217.0017.6% of flowISIN SE0002148817FI:csv-a4be1c24b4525920fab5
    Canonical exit: 9 Oct 2018 (T+90)
  • ▼
    KonsultExecutivesHansa Biopharma AB
    2M SEK23FI-SE
    12,000 shares@ SEK 203.0032.6% of flowISIN SE0002148817FI:csv-401c8e40289af08bd2ed
  • ▲
    KonsultExecutivesHansa Biopharma AB
    3M SEK6FI-SE
    14,000 shares@ SEK 202.0037.9% of flowISIN SE0002148817FI:csv-5b05f01f98e3dfd67795
    Canonical exit: 25 Sept 2018 (T+90)

4 of 4 declarations